AC
Acrivon Therapeutics, Inc. Common Stock (ACRV)
NASDAQ·Healthcare·Biotechnology
$2.07
-4.19%
Mkt Cap $52.70M
Analyst Ratings
No recent rating data.
Price Target (11 analysts)
$21.83
Range $17.00 – $30.00
Implied Upside
+957.1%
Consensus $21.83 vs current $2.07